reloacted from MD to VA at about time of PhaseI award, Nelson Scientific Labs is structured around discovery, development, and delivery of biomarkers for exposure assessment, in vitro diagnostics and precision medicine. Accessing and studying molecular profile data from diverse biological matrices using state-of-the-art analytic platforms for metabolomics, transcriptomics, and proteomics, the effort is to enable earlier detection of of their condition by cancer patients and health monitoring during curative radiation therapy - providing solutions of value to effective personalized treatment and to precision medicine that improve the cancer patientÂ’s clinical outcome.
